Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6)

By Juvonen R. O.   Gynther J.   Pasanen M.   Alhava E.   Poso A.  

Xenobiotica, Vol. 30, Iss. 1, 2000-01 ,pp. : 81-92

Informa Healthcare

Access to resources Recommend Favorite

Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4

By Lewis D. F. V.   Lake B. G.   P. M. Dickins   Eddershaw J.   Tarbit M. H.   Goldfarb P. S.  

Xenobiotica, Vol. 29, Iss. 4, 1999-04 ,pp. : 361-393

Informa Healthcare

Access to resources Recommend Favorite

CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6

By VON WEYMARN L. B.   MURPHY S. E.  

Xenobiotica, Vol. 33, Iss. 1, 2003-01 ,pp. : 73-81

Informa Healthcare

Access to resources Recommend Favorite

The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation

By Duarte Maria Paula  

Mutagenesis, Vol. 20, Iss. 2, 2005-03 ,pp. : 93-100

Oxford University Press

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite